BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Prognosis
13 results:

  • 1. Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy
    Miyamoto T; Sanford D; Tomuleasa C; Hsiao HH; Olivera LJE; Enjeti AK; Gimenez Conca A; Castillo TBD; Girshova L; Martelli MP; Guvenc B; Delgado A; Duan Y; Garbayo Guijarro B; Llamas C; Lee JH
    Leuk Lymphoma; 2022 Apr; 63(4):928-938. PubMed ID: 35147482
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Erythrophagocytosis by blast cells and de novo T cell LAL without cytogenetic abnormalities in a Moroccan patient].
    Kahouli S; Zahid H; Khorassani ME; Kabbaj SE; Benkirane M; Messaoudi N
    Pan Afr Med J; 2020; 36():202. PubMed ID: 32963668
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prevalence and effects of polypharmacy on overall survival in acute myeloid leukemia.
    Dhakal P; Lyden E; Muir KE; Al-Kadhimi ZS; Koll T; Maness LJ; Gundabolu K; Bhatt VR
    Leuk Lymphoma; 2020 Jul; 61(7):1702-1708. PubMed ID: 32157936
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Expression Difference of rhoh Gene in leukemia and Its Clinical Significance].
    Ni J; Shi QQ; Wu W; Sun X; Fang YZ; Gu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):758-762. PubMed ID: 31204928
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CD38 in Hairy Cell leukemia Is a Marker of Poor prognosis and a New Target for Therapy.
    Poret N; Fu Q; Guihard S; Cheok M; Miller K; Zeng G; Quesnel B; Troussard X; Galiègue-Zouitina S; Shelley CS
    Cancer Res; 2015 Sep; 75(18):3902-11. PubMed ID: 26170397
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
    Gkotzamanidou M; Papadimitriou CA
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.
    Okamoto R; Ogawa S; Nowak D; Kawamata N; Akagi T; Kato M; Sanada M; Weiss T; Haferlach C; Dugas M; Ruckert C; Haferlach T; Koeffler HP
    Haematologica; 2010 Sep; 95(9):1481-8. PubMed ID: 20435627
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic implication and biological roles of rhoh in acute myeloid leukaemia.
    Iwasaki T; Katsumi A; Kiyoi H; Tanizaki R; Ishikawa Y; Ozeki K; Kobayashi M; Abe A; Matsushita T; Watanabe T; Amano M; Kojima T; Kaibuchi K; Naoe T
    Eur J Haematol; 2008 Dec; 81(6):454-60. PubMed ID: 18691253
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.
    Kawamata N; Ogawa S; Zimmermann M; Kato M; Sanada M; Hemminki K; Yamatomo G; Nannya Y; Koehler R; Flohr T; Miller CW; Harbott J; Ludwig WD; Stanulla M; Schrappe M; Bartram CR; Koeffler HP
    Blood; 2008 Jan; 111(2):776-84. PubMed ID: 17890455
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Time to first flare-up episode of GVHD can stratify patients according to their prognosis during clinical course of progressive- or quiescent-type chronic GVHD.
    Kim DH; Sohn SK; Baek JH; Lee KH; Lee JH; Choi SJ; Shin IH
    Bone Marrow Transplant; 2007 Oct; 40(8):779-84. PubMed ID: 17700602
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome.
    Terol MJ; Tormo M; Martinez-Climent JA; Marugan I; Benet I; Ferrandez A; Teruel A; Ferrer R; García-Conde J
    Ann Oncol; 2003 Mar; 14(3):467-74. PubMed ID: 12598355
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients.
    Oinonen R; Franssila K; Teerenhovi L; Lappalainen K; Elonen E
    Eur J Cancer; 1998 Feb; 34(3):329-36. PubMed ID: 9640217
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The clinical relevance of t(14;18)/BCL-2 rearrangement and DEL 6q in diffuse large cell lymphoma and immunoblastic lymphoma.
    Romaguera JE; Pugh W; Luthra R; Goodacre A; Cabanillas F
    Ann Oncol; 1993 Jan; 4(1):51-4. PubMed ID: 8435363
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.